U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145164) titled 'Interleukin-15 to Promote Post-ART Control of HIV' on Aug. 20.
Brief Summary: Even though HIV medicine stops the virus from making more copies of itself, the virus remains in the body by hiding inside of immune cells. This hidden virus is referred to as the "latent reservoir." Researchers on this team are studying whether stimulating the immune system can change the nature of the latent reservoir and if this could help people control HIV without the need to take regular HIV medicine.
This study is testing a drug called N-803. N-803 is also known as Interleukin-15 or "IL-15", a powerful and long lasting protein that can affect the i...